Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer	Adult	Recruiting	Phase 2	2026-04-15		NCT06241781

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Grit Biotechnology	19

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Zhongshan Hospital Dalian University	Dalian	China	3
Chinese Academy of Medical Sciences Cancer Hospital Shenzhen Hospital	Shenzhen	China	2
Dalian Medical University First Affiliated Hospital	Dalian	China	1
Fudan University Affiliated Obstetrics and Gynecology Hospital	Shanghai	China	1
Fudan University Shanghai Cancer Center	Shanghai	China	257
Fujian Cancer Hospital	Fuzhou	China	109
Guangxi Medical University Affiliated Cancer Hospital	Guilin	China	1
Harbin Medical University Affiliated Cancer Hospital	Ha’erbin	China	1
Henan Cancer Hospital	Zhengzhou	China	57
Hubei Cancer Hospital	Wuhan	China	95
Jiangxi Maternal and Child Health Hospital	Nanchang	China	5
Jining First People's Hospital	Jining	China	2
Shandong First Medical University Affiliated Cancer Hospital	Jinan	China	3
Shanxi Cancer Hospital	Taiyuan	China	19
Sichuan University West China Second Hospital	Chengdu	China	1
Southeast University Affiliated Zhongda Hospital	Nanjing	China	1
The Fifth Medical Center of the General Hospital of the People's Liberation Army of China	Beijing	China	1
The First Affiliated Hospital of Henan University of science and Technology	Luoyang	China	5
The First Affiliated Hospital of Xi'an Jiaotong University	Xi’an	China	29
Tianjin Cancer Hospital	Tianjin	China	2
Xiangya Second Hospital of Central South University	Changsha	China	1
Yibin Second People's Hospital	Yibin	China	2
Yun Cancer Hospital	Kunming	China	1
Zhejiang Cancer Hospital	Hangzhou	China	34

Clinical trials